http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2497584-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51a0c49e5390c69aa92b87c3a892344c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-56 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-56 |
filingDate | 2003-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67fcc69a2ca9a3314d17cec21cd2d64e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_107f7c1a65002fd58900ca14ad2acf9b |
publicationDate | 2004-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2497584-A1 |
titleOfInvention | 2-heterosubstituted 3-aryl-4h-1-benzopyran-4-ones as novel therapeutics in breast cancer |
abstract | The present invention provides 2-heterosubstituted 3-aryl-4H-benzopyran-4-one compounds for the treatment of cancers, namely breast cancer. This invention further provides a method of synthesis of 2-(alkylthio)isoflavones that can be carried out at ambient conditions. This invention further provides a method of synthesis of the 2-heterosubstituted 3-aryl-4H-benzopyran-4-one from a 2-(alkylthio)isoflavone. The invention further provides methods of using the 2-heterosubstitured 3-aryl-4H-benzopyran-4-one compounds for the treatment of breast cancer in mammals. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8476313-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009253715-A1 |
priorityDate | 2002-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.